Gastro-oesophageal Reflux Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 20 years of age or older at the time of signing the consent form (confirm with trial site)
- People whose symptoms of acid reflux or heartburn score 8 or higher on a specific questionnaire called the GerdQ, assessed at the first visit
- People who choose to take part willingly and sign a written consent form
Who may not be able to join:
- People who have had allergic reactions or sensitivity to a group of medications called Benzimidazoles, or to any ingredient in the study drug
- People who are currently taking medications containing Atazanavir, Nelfinavir, or Rilpivirine (these are certain antiviral medicines)
- Women who are currently pregnant or breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 82-31-5176-4673
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Symptom improvement rate at 4 weeks after administration of K-CAB Tablet/K-CAB ODT.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.